Persisting IL-18 levels after COVID-19 correlate with markers of cardiovascular inflammation reflecting potential risk of CVDs development

Logo poskytovatele

Varování

Publikace nespadá pod Ekonomicko-správní fakultu, ale pod Lékařskou fakultu. Oficiální stránka publikace je na webu muni.cz.
Autoři

ANDREJČINOVÁ Ivana BLAZKOVA Gabriela PAPATHEODOROU Ioanna BENDÍČKOVÁ Kamila BOSÁKOVÁ Veronika SKOTAKOVA Monika PANOVSKÝ Roman OPATŘIL Lukáš VYMAZAL Ondřej KOVAČOVICOVÁ Petra ŠRÁMEK Vladimír HELÁN Martin HORTOVÁ KOHOUTKOVÁ Marcela FRIČ Jan

Rok publikování 2024
Druh Článek v odborném periodiku
Časopis / Zdroj Heliyon
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www https://www.sciencedirect.com/science/article/pii/S2405844024019698?via%3Dihub
Doi http://dx.doi.org/10.1016/j.heliyon.2024.e25938
Klíčová slova COVID-19; Inflammation; CVDs; COVID-19 long-term consequences; IL-18
Přiložené soubory
Popis COVID-19 manifestation is associated with a strong immune system activation leading to inflammation and subsequently affecting the cardiovascular system. The objective of the study was to reveal possible interconnection between prolongated inflammation and the development or exacerbation of long-term cardiovascular complications after COVID-19. We investigated correlations between humoral and cellular immune system markers together with markers of cardiovascular inflammation/ dysfunction during COVID-19 onset and subsequent recovery. We analyzed 22 hospitalized patients with severe COVID-19 within three timepoints (acute, 1 and 6 months after COVID-19) in order to track the impact of COVID-19 on the long-term decline of the cardiovascular system fitness and eventual development of CVDs. Among the cytokines dysregulated during COVID-19 changes, we showed significant correlations of IL-18 as a key driver of several pathophysiological changes with markers of cardiovascular inflammation/dysfunction. Our findings established novel immune-related markers, which can be used for the stratification of patients at high risk of CVDs for further therapy.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.